Target intelligence / Profile preview

ASH2L pseudogene 4 (ASH2LP4)

Target
ASH2LP4
Molecular classification
Other (pseudogene)
01

Overview

ASH2L pseudogene 4 (ASH2LP4) is a pseudogene, a DNA sequence similar to the ASH2L gene but generally considered non-functional because it does not code for an active protein. Unlike the functional ASH2L gene (Absent, small, or homeotic discs-like protein 2), which encodes a core component of MLL family histone methyltransferases important for chromatin regulation and cell proliferation[1][2][3], ASH2LP4 lacks coding potential and is not characterized as a therapeutic molecular target. ASH2LP4 has no documented role in biological function, disease association, molecular interaction, or relevance as a drug target. Relevant context: - The functional ASH2L gene is a protein-coding gene involved in histone methylation, cell proliferation, and transcription regulation and has disease relevance in cancer, especially leukemia[2][3][4]. - Pseudogenes like ASH2LP4 are typically not expressed as proteins and are not regarded as drug targets or functional molecular entities in therapeutics or diagnostics. There is no evidence in current biomedical databases or the literature that ASH2LP4 should be considered a receptor, enzyme, transporter, transcription factor, or other therapeutic target. If you intended to refer to functional ASH2L (and not the pseudogene), please clarify, as ASH2L itself is biologically and clinically relevant[1][2][3][4].

Beyond the preview

Go deeper on ASH2L pseudogene 4 (ASH2LP4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ASH2L pseudogene 4 (ASH2LP4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call